Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Paramount Cosmetics (India) Ltd

PARMCOS-B
BSE
36.00
2.70%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Paramount Cosmetics (India) Ltd

PARMCOS-B
BSE
36.00
2.70%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
17Cr
Close
Close Price
36.00
Industry
Industry
Personal Care
PE
Price To Earnings
62.07
PS
Price To Sales
0.71
Revenue
Revenue
25Cr
Rev Gr TTM
Revenue Growth TTM
25.99%
PAT Gr TTM
PAT Growth TTM
-147.06%
Peer Comparison
How does PARMCOS-B stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
PARMCOS-B
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
756654566595
Growth YoY
Revenue Growth YoY%
28.8-10.9-6.6-20.2-31.4-21.4-10.0-11.517.325.869.4-5.9
Expenses
ExpensesCr
746653556485
Operating Profit
Operating ProfitCr
110000000000
OPM
OPM%
8.910.6-6.55.3-0.28.16.06.10.79.44.74.0
Other Income
Other IncomeCr
001000000000
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
102.6-20.060.050.0-520.0-75.0-93.8-33.390.5-700.01,200.050.0
NPM
NPM%
0.70.82.80.5-4.10.30.20.4-0.3-1.31.50.6
EPS
EPS
0.10.10.30.3-1.70.10.10.2-0.1-0.50.90.3

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
484935212224182027222025
Growth
Revenue Growth%
2.11.5-29.0-39.84.210.6-27.615.332.4-18.4-6.520.6
Expenses
ExpensesCr
434230161720152124211923
Operating Profit
Operating ProfitCr
5754443-13011
OPM
OPM%
10.213.715.321.420.116.214.8-4.69.91.94.84.5
Other Income
Other IncomeCr
000000150211
Interest Expense
Interest ExpenseCr
233332222222
Depreciation
DepreciationCr
132211111110
PBT
PBTCr
210010000000
Tax
TaxCr
110011000000
PAT
PATCr
210000000000
Growth
PAT Growth%
15.6-54.0-111.7139.2-448.07.8391.1-42.98.2-89.940.2166.7
NPM
NPM%
3.61.6-0.30.2-0.6-0.52.01.00.80.10.10.3
EPS
EPS
3.61.6-0.20.1-0.3-0.20.70.40.40.00.10.6

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
555555555555
Reserves
ReservesCr
191915151515151515151616
Current Liabilities
Current LiabilitiesCr
272821192123221915151616
Non Current Liabilities
Non Current LiabilitiesCr
14139787798543
Total Liabilities
Total LiabilitiesCr
646551484849484743414039
Current Assets
Current AssetsCr
383927252225252521252625
Non Current Assets
Non Current AssetsCr
272624222625242322151514
Total Assets
Total AssetsCr
646551484849484743414039

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
70644421401
Investing Cash Flow
Investing Cash FlowCr
-82-100004021
Financing Cash Flow
Financing Cash FlowCr
1-4-6-4-4-4-2-5-4-2-2
Net Cash Flow
Net Cash FlowCr
0-2000000000
Free Cash Flow
Free Cash FlowCr
-12644425411
CFO To PAT
CFO To PAT%
413.448.9-6,878.610,334.6-3,455.6-3,605.7660.9417.31,725.0-1,100.04,681.3
CFO To EBITDA
CFO To EBITDA%
145.75.8120.884.4100.4108.587.5-88.8137.8-55.8142.6

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1617161496823171819
Price To Earnings
Price To Earnings
9.822.20.0355.60.00.022.6116.078.2944.8666.7
Price To Sales
Price To Sales
0.30.30.50.70.40.20.51.10.60.80.9
Price To Book
Price To Book
0.70.70.80.70.50.30.41.10.80.90.9
EV To EBITDA
EV To EBITDA
7.55.66.36.96.15.58.8-37.710.868.929.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.039.452.779.778.377.082.669.354.528.935.9
OPM
OPM%
10.213.715.321.420.116.214.8-4.69.91.94.8
NPM
NPM%
3.61.6-0.30.2-0.6-0.52.01.00.80.10.1
ROCE
ROCE%
9.29.78.48.27.97.57.78.26.25.65.2
ROE
ROE%
7.43.3-0.50.2-0.7-0.61.81.01.10.10.1
ROA
ROA%
2.71.2-0.20.1-0.3-0.20.70.40.50.10.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Paramount Cosmetics (India) Limited (PCIL) is a specialized player in the Indian traditional color cosmetics segment, primarily operating under the well-established brand name **'SHILPA'**. Since **1985**, the company has focused on a single business segment involving products such as **Sticker Bindis, Kumkum, Sindoor, and Kajal**. PCIL is currently undergoing a fundamental strategic transformation, pivoting from a manufacturing-heavy model to a lean, **selling and distribution-focused entity** designed to capture the evolving "Indie Beauty" market. --- ### **Strategic Pivot: Transition to a Distribution-Led Model** Effective **December 1, 2022**, PCIL underwent a significant structural shift. The rights to manufacture and market 'Shilpa' products were withdrawn by the brand owner, **Paramount Kum Kum Private Limited (PKPL)**, a related party. * **Current Operational Role:** PCIL now serves as the primary **selling and distribution partner** for 'Shilpa' products manufactured by PKPL. This arrangement allows PCIL to onboard other third-party cosmetic brands into its portfolio, diversifying revenue streams beyond its legacy brand. * **Asset Monetization & Debt Reduction:** To improve liquidity and reduce operational overhead, the Board has approved the **disposal of non-core manufacturing assets** (Land, Building, and Plant & Machinery) located at **Hosur (Shoolagiri)** to PKPL for an estimated value of approximately **₹3 Crore** (with a minimum floor price of **₹60,00,000**). * **Property Divestment:** The company has also authorized the disposal of immovable property at **Pardi, Gujarat**, with an estimated realizable value of at least **₹60 Lakhs**. Proceeds are earmarked to address mortgages with **IDBI Bank** and enhance working capital. --- ### **Product Portfolio: Bridging Tradition and Modernity** The company specializes in the **Traditional and Color Cosmetics** segment, reimagining ethnic staples through innovation in product formats to target both traditional users and the **Gen Z and millennial** demographics. | Category | Key Products & Innovations | | :--- | :--- | | **Traditional Cosmetics** | **Bindis:** Evolved into designer fashion accessories with velvet textures and crystal embellishments. Recent launches include **antimicrobial bindis**. <br> **Kumkum & Sindoor:** Transitioned to liquid applicators in **Matte and Shimmer** formulations (e.g., Cheery Red and Scarlet Red). | | **Eye Cosmetics** | **Kajal:** Positioned as a beauty-wellness hybrid (herbal, smudge-proof, and Ayurvedic). <br> **Eyeliner:** Rapidly expanding range including liquid, gel, pencil, and felt-tip pens. | | **Color Cosmetics** | **Extended Range:** Includes foundational makeup such as lipstick, eyeshadow, mascara, blush, and nail polish. | | **Niche Positioning** | **Clean Beauty:** Focus on organic, herbal, and cruelty-free formulations to meet the demand for products free from harsh chemicals. | --- ### **Market Dynamics & Growth Projections** PCIL operates in a market where traditional accessories are being adopted as "style statements" for weddings and festivals. * **Kajal Segment:** Projected CAGR of **8% - 10%**, driven by wellness benefits and the rise of male grooming. * **Eyeliner Segment:** Market value projected to reach **USD 407.7 Million** by 2030 (CAGR of **2.7%**). * **Traditional Segment:** Steady growth of **3% - 4%** supported by cultural resurgence. **Strategic Growth Drivers:** * **Digital Transformation:** Increasing presence on platforms like **Nykaa, Amazon, and Etsy**, while exploring **AI and Augmented Reality (AR)** for virtual try-ons. * **Tier-II & Tier-III Expansion:** A 3-year plan to leverage the existing distribution network to reach deeper into rural and semi-urban India. * **Export Strategy:** Positioning Bindis and Kumkum as global fashion accessories within the international **Ayurvedic beauty** trend. --- ### **Financial Profile & Capital Structure** PCIL has maintained a stable but modest financial profile, with recent efforts focused on capital conservation and cost management. **Three-Year Financial Summary (Audited):** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Sales & Other Income** | **₹21.61 crore** | **₹23.89 crore** | **₹26.92 crore** | | **Profit After Tax (PAT)** | **₹3.00 lakhs** | **₹2.14 lakhs** | **₹21.18 lakhs** | | **Paid-up Equity Capital** | **₹4.86 crore** | **₹4.86 crore** | **₹4.86 crore** | | **Dividend Declared** | **Nil** | **Nil** | **Nil** | **Credit Ratings (as of March 2026):** * **Long-Term Bank Facilities:** **CARE B; Stable** (Totaling **₹7.53 crore**). * **Short-Term Bank Facilities:** **CARE A4** (Totaling **₹1.00 crore**). * **Debt Profile:** Includes Term Loans and Cash Credit with interest rates ranging from **8.04% to 9.5%** (Bank) and **14% to 21%** (NBFC). **Shareholding Pattern (as of March 31, 2025):** * **Promoter Group:** **74.78%** * **Public Holding:** **24.97%** * **Dematerialization:** **90.84%** of total shares are held in electronic form. --- ### **Governance & Leadership Continuity** To ensure stability during the business model transition, the company has secured long-term executive oversight: * **MD Re-appointment:** **Mr. Hiitesh Topiiwaalla** has been re-appointed as Managing Director for a **5-year term** (April 2026 – March 2031). * **Governance Amendment:** The **Articles of Association (AOA)** were altered in February 2026 to exempt the Managing Director from **retirement by rotation**, ensuring uninterrupted strategic leadership. --- ### **Risk Factors & Mitigation Strategies** The company manages risks through a dedicated **Risk Management Committee**, focusing on the following critical areas: **1. Statutory & Regulatory Liabilities:** The company has significant outstanding undisputed statutory dues (as of March 31, 2025): * **Income Tax & Interest:** **₹175.45 Lakhs** * **Interest on TDS:** **₹15.12 Lakhs** * **ESIC & PF Dues:** **₹13.10 Lakhs** (combined) **2. Operational Risks:** * **Inventory Management:** In **Q3 FY26**, the company wrote off **₹1.07 crore** in inventory due to spoilage and physical damage. * **Counterfeiting:** The brand faces significant competition from the unorganized sector producing spurious products, which threatens both revenue and brand equity. * **Currency Volatility:** Exposure to **USD-denominated import payables** is managed via **natural hedging**; the company does not currently use forward contracts. **3. Market Risks:** * **Consumer Trends:** Rapidly shifting preferences toward **eco-friendly packaging** and **natural formulations** require constant R&D. * **Economic Sensitivity:** Inflation impacts discretionary spending; the company noted a weak festive boost in late 2023 with only **7% sales growth**.